ICU Research Development vs Selling General Administrative Analysis

ICUI Stock

USD 167.81 0.65 0.39%

ICU Medical financial indicator trend analysis is infinitely more than just investigating ICU Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICU Medical is a good investment. Please check the relationship between ICU Medical Research Development and its Selling General Administrative accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

Research Development vs Selling General Administrative

Research Development vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICU Medical Research Development account and Selling General Administrative. At this time, the significance of the direction appears to have totally related.

The correlation between ICU Medical's Research Development and Selling General Administrative is 0.99. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of ICU Medical, assuming nothing else is changed. The correlation between historical values of ICU Medical's Research Development and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of ICU Medical are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Research Development i.e., ICU Medical's Research Development and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Selling General Administrative

Most indicators from ICU Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICU Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.As of now, ICU Medical's Selling General Administrative is increasing as compared to previous years. The ICU Medical's current Sales General And Administrative To Revenue is estimated to increase to 0.28, while Tax Provision is forecasted to increase to (46.2 M).

	2021	2022	2023	2024 (projected)
Gross Profit	491.5M	697.8M	739.9M	776.9M
Total Revenue	1.3B	2.3B	2.3B	2.4B

Gross Profit Total Revenue

ICU Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Total	Other Current Assets	Intangible Assets	Common Stock Total Equity	Short Term Investments	Common Stock	Other Assets
Total Assets		0.97	0.98	0.94	0.93	0.87	0.78	0.92	0.03	0.99	-0.31	-0.06	0.77	0.67	0.99	0.98	0.97	0.94	0.9	0.94	0.79	0.98	0.66	-0.36	0.73	0.81
Other Current Liab	0.97		0.99	0.97	0.97	0.77	0.82	0.94	0.09	0.93	-0.46	0.0	0.88	0.74	0.99	0.99	0.89	0.95	0.94	0.85	0.69	0.92	0.74	-0.42	0.79	0.88
Total Current Liabilities	0.98	0.99		0.96	0.96	0.82	0.79	0.96	0.03	0.96	-0.42	-0.06	0.85	0.71	1.0	0.99	0.93	0.94	0.92	0.89	0.71	0.95	0.7	-0.41	0.77	0.84
Total Stockholder Equity	0.94	0.97	0.96		0.99	0.67	0.93	0.92	0.29	0.89	-0.38	0.2	0.85	0.82	0.96	0.98	0.83	0.92	0.99	0.78	0.77	0.87	0.82	-0.36	0.86	0.93
Property Plant And Equipment Net	0.93	0.97	0.96	0.99		0.65	0.9	0.95	0.21	0.87	-0.48	0.12	0.88	0.81	0.96	0.98	0.8	0.9	0.96	0.75	0.73	0.85	0.81	-0.45	0.85	0.94
Net Debt	0.87	0.77	0.82	0.67	0.65		0.4	0.72	-0.4	0.93	-0.17	-0.47	0.48	0.28	0.83	0.78	0.97	0.81	0.58	0.98	0.65	0.94	0.28	-0.32	0.37	0.48
Retained Earnings	0.78	0.82	0.79	0.93	0.9	0.4		0.79	0.57	0.7	-0.21	0.52	0.76	0.9	0.8	0.84	0.61	0.75	0.95	0.55	0.73	0.67	0.89	-0.23	0.9	0.9
Accounts Payable	0.92	0.94	0.96	0.92	0.95	0.72	0.79		0.07	0.89	-0.41	-0.01	0.9	0.77	0.95	0.95	0.85	0.83	0.91	0.8	0.63	0.88	0.73	-0.41	0.81	0.81
Cash	0.03	0.09	0.03	0.29	0.21	-0.4	0.57	0.07		-0.09	0.08	0.98	0.18	0.59	0.03	0.12	-0.18	0.01	0.4	-0.23	0.22	-0.12	0.57	0.28	0.52	0.36
Non Current Assets Total	0.99	0.93	0.96	0.89	0.87	0.93	0.7	0.89	-0.09		-0.28	-0.17	0.7	0.58	0.97	0.95	0.99	0.93	0.83	0.98	0.78	1.0	0.57	-0.36	0.65	0.75
Non Currrent Assets Other	-0.31	-0.46	-0.42	-0.38	-0.48	-0.17	-0.21	-0.41	0.08	-0.28		0.21	-0.47	-0.2	-0.42	-0.44	-0.22	-0.43	-0.34	-0.17	-0.07	-0.26	-0.23	0.44	-0.2	-0.52
Cash And Short Term Investments	-0.06	0.0	-0.06	0.2	0.12	-0.47	0.52	-0.01	0.98	-0.17	0.21		0.1	0.52	-0.06	0.02	-0.26	-0.06	0.32	-0.3	0.15	-0.21	0.51	0.27	0.45	0.27
Net Receivables	0.77	0.88	0.85	0.85	0.88	0.48	0.76	0.9	0.18	0.7	-0.47	0.1		0.82	0.83	0.84	0.64	0.73	0.87	0.58	0.39	0.68	0.79	-0.39	0.83	0.76
Common Stock Shares Outstanding	0.67	0.74	0.71	0.82	0.81	0.28	0.9	0.77	0.59	0.58	-0.2	0.52	0.82		0.7	0.74	0.5	0.6	0.88	0.43	0.55	0.55	0.99	-0.22	0.99	0.79
Inventory	0.99	0.99	1.0	0.96	0.96	0.83	0.8	0.95	0.03	0.97	-0.42	-0.06	0.83	0.7		0.99	0.93	0.95	0.92	0.9	0.74	0.96	0.7	-0.41	0.76	0.85
Other Stockholder Equity	0.98	0.99	0.99	0.98	0.98	0.78	0.84	0.95	0.12	0.95	-0.44	0.02	0.84	0.74	0.99		0.91	0.95	0.95	0.86	0.75	0.93	0.73	-0.4	0.79	0.89
Total Liab	0.97	0.89	0.93	0.83	0.8	0.97	0.61	0.85	-0.18	0.99	-0.22	-0.26	0.64	0.5	0.93	0.91		0.89	0.76	1.0	0.74	0.99	0.48	-0.32	0.57	0.65
Property Plant And Equipment Gross	0.94	0.95	0.94	0.92	0.9	0.81	0.75	0.83	0.01	0.93	-0.43	-0.06	0.73	0.6	0.95	0.95	0.89		0.87	0.86	0.69	0.9	0.64	-0.39	0.66	0.83
Total Current Assets	0.9	0.94	0.92	0.99	0.96	0.58	0.95	0.91	0.4	0.83	-0.34	0.32	0.87	0.88	0.92	0.95	0.76	0.87		0.71	0.71	0.81	0.86	-0.3	0.9	0.91
Non Current Liabilities Total	0.94	0.85	0.89	0.78	0.75	0.98	0.55	0.8	-0.23	0.98	-0.17	-0.3	0.58	0.43	0.9	0.86	1.0	0.86	0.71		0.73	0.98	0.42	-0.29	0.51	0.59
Other Current Assets	0.79	0.69	0.71	0.77	0.73	0.65	0.73	0.63	0.22	0.78	-0.07	0.15	0.39	0.55	0.74	0.75	0.74	0.69	0.71	0.73		0.78	0.54	-0.28	0.61	0.77
Intangible Assets	0.98	0.92	0.95	0.87	0.85	0.94	0.67	0.88	-0.12	1.0	-0.26	-0.21	0.68	0.55	0.96	0.93	0.99	0.9	0.81	0.98	0.78		0.54	-0.35	0.63	0.72
Common Stock Total Equity	0.66	0.74	0.7	0.82	0.81	0.28	0.89	0.73	0.57	0.57	-0.23	0.51	0.79	0.99	0.7	0.73	0.48	0.64	0.86	0.42	0.54	0.54		-0.26	0.98	0.79
Short Term Investments	-0.36	-0.42	-0.41	-0.36	-0.45	-0.32	-0.23	-0.41	0.28	-0.36	0.44	0.27	-0.39	-0.22	-0.41	-0.4	-0.32	-0.39	-0.3	-0.29	-0.28	-0.35	-0.26		-0.28	-0.4
Common Stock	0.73	0.79	0.77	0.86	0.85	0.37	0.9	0.81	0.52	0.65	-0.2	0.45	0.83	0.99	0.76	0.79	0.57	0.66	0.9	0.51	0.61	0.63	0.98	-0.28		0.81
Other Assets	0.81	0.88	0.84	0.93	0.94	0.48	0.9	0.81	0.36	0.75	-0.52	0.27	0.76	0.79	0.85	0.89	0.65	0.83	0.91	0.59	0.77	0.72	0.79	-0.4	0.81

Click cells to compare fundamentals

ICU Medical Account Relationship Matchups

ICU Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.7B	1.8B	1.9B	4.5B	4.4B	4.6B
Other Current Liab	105.8M	109.0M	96.5M	192.9M	213.7M	224.4M
Total Current Liabilities	248.5M	195.5M	200.8M	494.6M	481.8M	505.9M
Total Stockholder Equity	1.4B	1.5B	1.6B	2.1B	2.1B	2.2B
Property Plant And Equipment Net	490.6M	513.2M	508.2M	711.0M	685.5M	719.8M
Net Debt	(232.4M)	(344.0M)	(507.8M)	1.4B	1.5B	1.5B
Retained Earnings	721.8M	808.7M	911.8M	837.5M	807.8M	848.2M
Accounts Payable	128.6M	71.9M	81.1M	215.9M	150.0M	157.5M
Cash	268.7M	396.1M	552.8M	208.8M	254.2M	137.4M
Non Current Assets Total	810.2M	842.9M	850.9M	3.3B	3.2B	3.3B
Non Currrent Assets Other	49.0M	55.5M	63.7M	105.5M	52.0M	54.6M
Cash And Short Term Investments	292.6M	410.8M	567.2M	213.0M	254.7M	178.0M
Net Receivables	202.2M	124.1M	105.9M	221.7M	182.1M	191.3M
Common Stock Shares Outstanding	21.5M	21.6M	21.8M	23.9M	24.1M	17.2M
Liabilities And Stockholders Equity	1.7B	1.8B	1.9B	4.5B	4.4B	4.6B
Inventory	337.6M	314.9M	290.2M	696.0M	709.4M	744.8M
Other Stockholder Equity	668.8M	693.0M	721.4M	1.3B	1.4B	1.4B
Total Liab	315.1M	261.4M	264.7M	2.4B	2.3B	2.4B
Property Plant And Equipment Gross	490.6M	513.2M	468.4M	711.0M	1.3B	1.4B
Total Current Assets	882.2M	920.8M	1.0B	1.2B	1.2B	1.3B
Accumulated Other Comprehensive Income	(15.4M)	(1.5M)	(19.3M)	(81.0M)	(53.1M)	(50.4M)
Non Current Liabilities Total	66.7M	65.9M	63.9M	1.9B	1.8B	1.9B
Other Current Assets	4.4M	85.5M	71.3M	101.6M	75.0M	78.8M
Intangible Assets	211.4M	197.2M	188.3M	982.8M	870.6M	914.1M
Common Stock Total Equity	2.0M	2.1M	2.1M	2.1M	2.4M	1.7M
Short Term Investments	24.0M	14.7M	14.4M	4.2M	501K	476.0K
Common Stock	2.1M	2.1M	2.1M	2.4M	2.4M	1.8M
Other Assets	77.0M	146.1M	106.3M	104.4M	120.1M	126.1M
Treasury Stock	(95K)	(157K)	(39K)	(27K)	(31.1K)	(32.6K)
Property Plant Equipment	456.1M	466.6M	468.4M	713.6M	820.6M	861.6M
Other Liab	37.8M	18.1M	22.1M	244.7M	281.4M	295.5M
Net Tangible Assets	1.2B	1.3B	1.6B	(342.1M)	(393.4M)	(373.7M)
Current Deferred Revenue	6.7M	5.6M	12.6M	30.8M	31.6M	33.2M
Good Will	31.2M	33.0M	43.4M	1.4B	1.5B	1.5B
Retained Earnings Total Equity	620.7M	721.8M	808.7M	911.8M	1.0B	553.4M
Capital Surpluse	657.9M	668.9M	693.1M	721.4M	829.6M	871.1M
Deferred Long Term Liab	2.1M	1.7M	1.5M	5.2M	4.6M	2.7M
Long Term Investments	0.0	13.0M	4.6M	3.7M	3.1M	4.2M
Non Current Liabilities Other	47.3M	64.3M	62.4M	54.4M	33.9M	27.4M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:

How To Invest In ICU

Details

Is ICU Stock a good investment?

Details

What is ICU Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Earnings Share

(4.57)

Revenue Per Share

96.302

Quarterly Revenue Growth

0.065

Return On Assets

0.0066

The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ICU Research Development vs Selling General Administrative Analysis

Research Development vs Selling General Administrative

Research Development vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Research Development

Selling General Administrative

ICU Medical fundamental ratios Correlations

ICU Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ICU Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Inventory	+ 1.0	Total Current Liabilities
Intangible Assets	+ 1.0	Non Current Assets Total
Non Current Liabilities Total	+ 1.0	Total Liab
Non Current Assets Total	+ 0.99	Total Assets
Inventory	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab

Other Assets	- 0.52	Non Currrent Assets Other
Non Currrent Assets Other	- 0.48	Property Plant And Equipment Net
Net Receivables	- 0.47	Non Currrent Assets Other
Cash And Short Term Investments	- 0.47	Net Debt
Non Currrent Assets Other	- 0.46	Other Current Liab
Short Term Investments	- 0.45	Property Plant And Equipment Net